| Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer S Adamia, CA Maxwell, LM Pilarski Current Drug Targets-Cardiovascular & Hematological Disorders 5 (1), 3-14, 2005 | 223 | 2005 |
| Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs X Leleu, J Soumerai, A Roccaro, E Hatjiharissi, ZR Hunter, R Manning, ... Journal of Clinical Oncology 27 (2), 250-255, 2009 | 194 | 2009 |
| A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells EG Cen, C Dalton, Y Li, S Adamia, LM Pilarski, KVIS Kaler Journal of microbiological methods 58 (3), 387-401, 2004 | 189 | 2004 |
| Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications J Jakubikova, S Adamia, M Kost-Alimova, S Klippel, D Cervi, JF Daley, ... Blood, The Journal of the American Society of Hematology 117 (17), 4409-4419, 2011 | 183 | 2011 |
| RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma CA Maxwell, E Rasmussen, F Zhan, JJ Keats, S Adamia, E Strachan, ... Blood 104 (4), 1151-1158, 2004 | 124 | 2004 |
| Small volume PCR in PDMS biochips with integrated fluid control and vapour barrier AR Prakash, S Adamia, V Sieben, P Pilarski, LM Pilarski, CJ Backhouse Sensors and Actuators B: Chemical 113 (1), 398-409, 2006 | 120 | 2006 |
| Peanut lectin binds to a subpopulation of mitochondria-rich cells in the rainbow trout gill epithelium GG Goss, S Adamia, F Galvez American Journal of Physiology-Regulatory, Integrative and Comparative …, 2001 | 118 | 2001 |
| Inhibition of USP10 induces degradation of oncogenic FLT3 EL Weisberg, NJ Schauer, J Yang, I Lamberto, L Doherty, S Bhatt, ... Nature chemical biology 13 (12), 1207-1215, 2017 | 117 | 2017 |
| A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets S Adamia, B Haibe-Kains, PM Pilarski, M Bar-Natan, S Pevzner, ... Clinical cancer research 20 (5), 1135-1145, 2014 | 114 | 2014 |
| Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells M Cea, A Cagnetta, S Adamia, C Acharya, YT Tai, M Fulciniti, H Ohguchi, ... Blood, The Journal of the American Society of Hematology 127 (9), 1138-1150, 2016 | 113 | 2016 |
| Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia S Bhatt, MS Pioso, EA Olesinski, B Yilma, JA Ryan, T Mashaka, B Leutz, ... Cancer cell 38 (6), 872-890. e6, 2020 | 99 | 2020 |
| Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice J Etchin, J Montero, A Berezovskaya, BT Le, A Kentsis, AL Christie, ... Leukemia 30 (1), 0-0, 2016 | 96 | 2016 |
| Establishment of BCWM. 1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice DD Santos, AW Ho, O Tournilhac, E Hatjiharissi, X Leleu, L Xu, P Tassone, ... Experimental hematology 35 (9), 1366-1375, 2007 | 86 | 2007 |
| Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRα, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants E Weisberg, HG Choi, A Ray, R Barrett, J Zhang, T Sim, W Zhou, ... Blood, The Journal of the American Society of Hematology 115 (21), 4206-4216, 2010 | 83 | 2010 |
| Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells E Weisberg, RD Wright, DW McMillin, C Mitsiades, A Ray, R Barrett, ... Molecular cancer therapeutics 7 (5), 1121-1129, 2008 | 82 | 2008 |
| Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma S Adamia, T Reiman, M Crainie, MJ Mant, AR Belch, LM Pilarski Blood 105 (12), 4836-4844, 2005 | 82 | 2005 |
| The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications D Ogiya, J Liu, H Ohguchi, K Kurata, MK Samur, YT Tai, S Adamia, ... Blood, The Journal of the American Society of Hematology 136 (20), 2334-2345, 2020 | 78 | 2020 |
| Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics A Cagnetta, S Adamia, C Acharya, F Patrone, M Miglino, A Nencioni, ... Leukemia research 38 (6), 649-659, 2014 | 63 | 2014 |
| miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth M Fulciniti, N Amodio, RL Bandi, A Cagnetta, MK Samur, C Acharya, ... Blood cancer journal 6 (1), e380-e380, 2016 | 62 | 2016 |
| Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells E Weisberg, A Ray, E Nelson, S Adamia, R Barrett, M Sattler, C Zhang, ... PloS one 6 (9), e25351, 2011 | 61 | 2011 |
Linda M. PilarskiProfessor, Dept Oncology, University of Alberta and Cross Cancer InstituteVerified email at ualberta.ca
